When did THERIVA BIOLOGICS INC (TOVX) report earnings last quarter?
THERIVA BIOLOGICS INC (TOVX) last reported earnings on 3/12/2026.
THERIVA BIOLOGICS INC (TOVX) Earnings History & Surprises
NYSEARCA:TOVX • US87164U5083
Current stock price
0.2506 USD
+0 (+0.24%)
Last:
TOVX Earnings overview
Past quarterly earnings results for THERIVA BIOLOGICS INC (TOVX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.12
- EPS Surprise
- 73.01%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.12 | -0.44 | 73.01% | 96.37% | - | - | ||
| Q3 2025 | -0.45 | -0.77 | 41.57% | 93.39% | - | - | ||
| Q2 2025 | -0.57 | -0.93 | 38.93% | -99.58% | - | - | ||
| Q1 2025 | -1.55 | -4.27 | 63.73% | 79.33% | - | - | ||
| Q4 2024 | -3.30 | -6.49 | 49.15% | 61.19% | - | - | ||
| Q3 2024 | -6.81 | -6.38 | -6.82% | -43.37% | - | - | ||
| Q2 2024 | -0.29 | - | 96.64% | - | - | |||
| Q1 2024 | -7.50 | -8.67 | 13.49% | - | - | - | ||
| Q4 2023 | -8.50 | -10.46 | 18.70% | -3.03% | - | - | ||
| Q3 2023 | -4.75 | -9.56 | 50.33% | 42.42% | - | - | ||
| Q2 2023 | -8.50 | -9.18 | 7.41% | -9.68% | - | - | ||
| Q1 2023 | -7.50 | -8.16 | 8.09% | - | - | - | ||
| Q4 2022 | -8.25 | -8.54 | 3.42% | 17.50% | - | - | ||
| Q3 2022 | -8.25 | -10.07 | 18.09% | -65.00% | - | - | ||
| Q2 2022 | -7.75 | -8.93 | 13.17% | -55.00% | - | - | ||
| Q1 2022 | -7.50 | -7.65 | 1.96% | 76.92% | - | - | ||
| Q4 2021 | -10.00 | -7.65 | -30.72% | 71.43% | - | - | ||
| Q3 2021 | -5.00 | -6.38 | 21.57% | 85.71% | - | - | ||
| Q2 2021 | -5.00 | -5.10 | 1.96% | 87.50% | - | - | ||
| Q1 2021 | -32.50 | -5.10 | -537.25% | 23.53% | - | - | ||
| Q4 2020 | -35.00 | -20.40 | -71.57% | - | - | - | ||
| Q3 2020 | -35.00 | -43.35 | 19.26% | - | - | - | ||
| Q2 2020 | -40.00 | -40.80 | 1.96% | - | - | - | ||
| Q1 2020 | -42.50 | -68.85 | 38.27% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
54.31%
Max EPS beat (4)
73.01%
Min EPS beat (4)
38.93%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, TOVX has consistently beaten EPS estimates in all releases
In the last 4 quarters, TOVX has beaten the EPS estimates by 54.3% on average.
Related analysis
THERIVA BIOLOGICS INC / TOVX Earnings FAQ
Can you provide information on whether THERIVA BIOLOGICS INC beat earnings estimates in the last quarter?
THERIVA BIOLOGICS INC (TOVX) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often THERIVA BIOLOGICS INC beats earnings estimates?
In the last 4 quarters, THERIVA BIOLOGICS INC (TOVX) has beaten EPS estimates in 4 out of 4 releases.